Tesamorelin, a growth hormone-releasing analog, increased IGF-1 levels by an average of 181 micrograms per liter in both men and women
But the null finding is notable because it suggests that GLP-1 appetite suppression may already be near the ceiling of what appetite reduction can achieve, leaving little room for phentermine to add benefit
Recent industry briefings and research summaries have highlighted increasing discussion around growth hormonereleasing peptides such as CJC-1295 and Ipamorelin , alongside a parallel rise in structured supplement stacks designed to support similar biological pathways through non-peptide formulations
This resistance can be caused by a multitude of factors, though recent research points to excessive visceral fat as one of the main ones (6)
Fatty acids are utilized as an energy substrate in all tissues except the brain
In a research setting, this accomplishes two critical things: It magnifies the amount of GH released during the pulse that CJC-1295 started